Company · CIK 1714899

# Denali Therapeutics Inc.

| CIK | [1714899](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001714899) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | DNLI (Nasdaq) |
| First annual or quarterly report | 2018-03-19 |

## Offerings

 5 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-285326 | Shelf Effective | 2025-02-27 | 2025-12-10 | 3 |
| 333-278174 | Shelf Effective | 2024-03-22 | 2024-03-22 | 1 |
| 333-263107 | Shelf Effective | 2022-02-28 | 2022-10-20 | 3 |
| 333-230232 | Shelf Effective | 2019-03-12 | 2020-01-29 | 3 |
| 333-221522 | IPO Final prospectus | 2017-11-13 | 2017-12-08 | 5 |

## Filings

 16

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-10 | [424B5](https://www.sec.gov/Archives/edgar/data/1714899/000162828025056361/0001628280-25-056361-index.htm) Shelf takedown | 333-285326 | 0001628280-25-056361 |
| 2025-12-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1714899/000162828025056085/0001628280-25-056085-index.htm) Shelf takedown | 333-285326 | 0001628280-25-056085 |
| 2025-02-27 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1714899/000162828025008647/0001628280-25-008647-index.htm) Shelf registered | 333-285326 | 0001628280-25-008647 |
| 2024-03-22 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1714899/000171489924000096/0001714899-24-000096-index.htm) Shelf registered | 333-278174 | 0001714899-24-000096 |
| 2022-10-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1714899/000162828022026763/0001628280-22-026763-index.htm) Shelf takedown | 333-263107 | 0001628280-22-026763 |
| 2022-10-18 | [424B5](https://www.sec.gov/Archives/edgar/data/1714899/000162828022026571/0001628280-22-026571-index.htm) Shelf takedown | 333-263107 | 0001628280-22-026571 |
| 2022-02-28 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1714899/000162828022004297/0001628280-22-004297-index.htm) Shelf registered | 333-263107 | 0001628280-22-004297 |
| 2020-01-29 | [424B5](https://www.sec.gov/Archives/edgar/data/1714899/000162828020000680/0001628280-20-000680-index.htm) Shelf takedown | 333-230232 | 0001628280-20-000680 |
| 2020-01-27 | [424B5](https://www.sec.gov/Archives/edgar/data/1714899/000162828020000564/0001628280-20-000564-index.htm) Shelf takedown | 333-230232 | 0001628280-20-000564 |
| 2019-03-12 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1714899/000171489919000018/0001714899-19-000018-index.htm) Shelf registered | 333-230232 | 0001714899-19-000018 |
| 2017-12-08 | [424B4](https://www.sec.gov/Archives/edgar/data/1714899/000119312517364327/0001193125-17-364327-index.htm) Final prospectus | 333-221522 | 0001193125-17-364327 |
| 2017-12-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1714899/999999999517003174/9999999995-17-003174-index.htm) Declared effective | 333-221522 | 9999999995-17-003174 |
| 2017-12-07 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1714899/000119312517363254/0001193125-17-363254-index.htm) Amendment | 333-221522 | 0001193125-17-363254 |
| 2017-11-27 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1714899/000119312517351618/0001193125-17-351618-index.htm) Amendment | 333-221522 | 0001193125-17-351618 |
| 2017-11-13 | [S-1](https://www.sec.gov/Archives/edgar/data/1714899/000119312517340997/0001193125-17-340997-index.htm) Registration filed | 333-221522 | 0001193125-17-340997 |
| 2017-09-08 | [DRS](https://www.sec.gov/Archives/edgar/data/1714899/000095012317008432/0000950123-17-008432-index.htm) Draft made public | 377-01709 | 0000950123-17-008432 |

[All filings of this company](https://equitycapital.markets/filings?cik=1714899) · [CSV](https://equitycapital.markets/filings.csv?cik=1714899)

---
Source page: https://equitycapital.markets/company/1714899 · Data: U.S. SEC EDGAR · CC BY 4.0